Provided by Tiger Trade Technology Pte. Ltd.

Organon & Co

13.76
0.0000
Post-market: 13.770.0100+0.07%19:46 EDT
Volume:2.71M
Turnover:37.28M
Market Cap:3.61B
PE:17.35
High:13.77
Open:13.76
Low:13.76
Close:13.76
52wk High:13.77
52wk Low:5.69
Shares:262.60M
Float Shares:243.00M
Volume Ratio:0.78
T/O Rate:1.11%
Dividend:0.08
Dividend Rate:0.58%
EPS(TTM):0.7929
EPS(LYR):0.7200
ROE:24.04%
ROA:5.67%
PB:3.59
PE(LYR):19.11

Loading ...

Organon Closes Deal to License Sebela Pharmaceuticals' Miudella Intrauterine Device

MT Newswires Live
·
Jun 22

Organon completes global MIUDELLA copper IUD licensing deal with Sebela

Reuters
·
Jun 22

Organon Completes Agreement to License Miudella®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device

THOMSON REUTERS
·
Jun 22

Organon & Co - Miudella Expected to Be Commercially Available in Late 2026

THOMSON REUTERS
·
Jun 22

Organon and Samsung Bioepis expand commercialization agreement for Pyzchiva

TIPRANKS
·
Jun 18

Organon, Samsung Bioepis expand Canada commercialization pact for ustekinumab biosimilar PYZCHIVA

Reuters
·
Jun 18

Organon & Co - Pyzchiva Expected to Launch in Canada in 2026

THOMSON REUTERS
·
Jun 18

Organon & Co - Agreement Expands Biosimilar Collaboration in Canada to Six Products

THOMSON REUTERS
·
Jun 18

Organon & Co - to Obtain Commercialization Rights to Pyzchiva in Canada

THOMSON REUTERS
·
Jun 18

Organon and Samsung Bioepis Expand Agreement to Commercialize Pyzchiva® (Ustekinumab), a Biosimilar Referencing Stelara® (Ustekinumab) in Canada

THOMSON REUTERS
·
Jun 18

Shore Capital Reaffirms Their Buy Rating on Origin Enterprises plc (OGN)

TIPRANKS
·
Jun 17

Organon shareholders approve amended 2021 incentive stock plan, adding 8 million shares

Reuters
·
Jun 12

Organon wins US approval to widen use of arthritis biosimilar drug

Reuters
·
Jun 10

Organon Expands Tofidence Label With FDA Approval for Additional Indications

MT Newswires Live
·
Jun 10

Organon announces U.S. FDA approval pf sBLA for Tofidence injection

TIPRANKS
·
Jun 10

Organon says FDA approves expanded TOFIDENCE use in CAR-T cytokine release syndrome

Reuters
·
Jun 10

Organon & Co - Tofidence Injection Available in 80 Mg, 200 Mg, 400 Mg Single-Dose Vials

THOMSON REUTERS
·
Jun 10

Organon Secures US Food and Drug Administration Approval Expanding Indications for Tofidence® (Tocilizumab-Bavi) in Cytokine Release Syndrome (Crs) and Pediatric Covid-19

THOMSON REUTERS
·
Jun 10

Market Chatter: Organon Acquisition May Receive $1 Billion Commitment From State Bank of India

MT Newswires Live
·
Jun 09

India's Sun Pharma posts profit beat on specialty drug demand, shares slide on cost pressures

Reuters
·
May 22